Table 3.
Direction of Change | Selected Scientific Articles | |
---|---|---|
Physiological (cardiovascular and metabolic parameters) | ||
| ||
Blood pressure | ↓ | (Park et al., 2010)1; (Twohig-Bennett & Jones, 2018)2; (Li et al., 2011)1; (Yang, Markevych, Bloom, et al., 2019)4 |
Diastolic blood pressure | ↓ | (Twohig-Bennett & Jones, 2018)2 |
| ||
Heart rate | ↓ | (Park et al., 2010)1; (Twohig-Bennett & Jones, 2018)2 |
| ||
Heart rate variability | ↑ | (Blum et al., 2019)1; (de Brito et al., 2020)1 |
Low frequency | ↓ | (Twohig-Bennett & Jones, 2018)2; (Park et al., 2017)3 |
High frequency | ↑ | (Twohig-Bennett & Jones, 2018)2 |
Nighttime | ↑ | (Gladwell et al., 2016)1 |
| ||
Body mass index (BMI) | ↓ | (Veitch et al., 2016)4; (Tilt et al., 2007)4; (Astell-Burt, Feng, et al., 2014a)4; (Li & Ghosh, 2018)4; (O’Callaghan-Gordo et al., 2020)4 |
| ||
Sleep/circadian rhythms | ||
Align internal rhythms with natural sunrise and sunset. | ↑ | (Wright et al., 2013)1 |
Sleep duration | ↑ | (Shin et al., 2020)2; (Johnson et al., 2018)4; (Astell-Burt & Feng, 2020a)4; (Wright et al., 2013)1 |
Sleep quality | ↑ | (Shin et al., 2020)2; (Pasanen et al., 2014)4 (Xie et al., 2020)4 |
| ||
HDL cholesterol | ↓ | (Twohig-Bennett & Jones, 2018)2; (Fan et al., 2020)4 |
| ||
Markers of oxidative stress | ↓ | (Mao, Lan, et al., 2012)1; (Mao, Cao, et al., 2012)1 |
Alpha-amylase | ↓ | (Egorov et al., 2017)4; (Hunter et al., 2019)3 |
Cortisol | ↓ | (Park et al., 2010)1; (Egorov et al., 2017)4; (Hunter et al., 2019)3; (Honold et al., 2016)4; (Gidlow et al., 2016)3; (Twohig-Bennett & Jones, 2018)2 |
| ||
Adiponectin | ↑ | (Li et al., 2011)1; (Li et al., 2016)1 |
| ||
Dehydroepiandrosterone sulfate | ↑ | (Li et al., 2011)1 |
| ||
Pro-inflammatory cytokines (e.g., IL-6; TNF-α) | ↓ | (Mao, Lan, et al., 2012)1; (Mao, Cao, et al., 2012)1; (Oh et al., 2017)2 |
| ||
Anti-inflammatory cytokines (e.g., IL-8) | ↑ | (Egorov et al., 2017)4 |
| ||
Natural Killer Cells | ↑ | (Li et al., 2007)1; (Li et al., 2009)1; (Tsao et al., 2018)1 |
| ||
Allostatic Load | ↓ | (Egorov et al., 2017)4; (Ribeiro et al., 2019) 4 |
| ||
Parasympathetic nerve activity | ||
Heart rate variability | ↑ | (Farrow & Washburn, 2019)2; (Park et al., 2010)1; (Park et al., 2017)1; (Lee et al., 2014)3; (Song et al., 2019) 1 |
| ||
Sympathetic nerve activity | ||
Heart rate variability | ↓ | (Farrow & Washburn, 2019)2; (Park et al., 2010)1; (Park et al., 2017)1; (Lee et al., 2014)3; (Song et al., 2019)1 |
Urine adrenaline/noradrenaline/dopamine | ↓ | (Li et al., 2008)1; (Li, 2010)1; (Li et al., 2011)1; (Li et al., 2016)1 |
| ||
Neurotransmitters | ||
Noradrenaline/adrenalin | ↓ | (Li et al., 2011)1; (Egorov et al., 2017)4 |
Dopamine | ↓ | (Li et al., 2011)1; (Li et al., 2016)1; (Egorov et al., 2017)4 |
| ||
Disease Prevalence/Risk | ||
Asthma | ↓ | (Twohig-Bennett & Jones, 2018)2; (Lovasi et al., 2008)4 |
Hypertension | ↓ | (Twohig-Bennett & Jones, 2018)2 |
Dyslipidemia | ↓ | (Twohig-Bennett & Jones, 2018)2 |
Obesity/metabolic syndrome | ↓ | (Nielsen & Hansen, 2007)4; (Lachowycz & Jones, 2011)2; (Ulmer et al., 2016)4; (Egorov et al., 2017)4; (Schalkwijk et al., 2018)4; Browning and Rigolon 20184; (O’Callaghan-Gordo et al., 2020)4; (Huang et al., 2020)4; (Yang et al., 2020)4; (de Keijzer et al., 2019)4 |
Stroke | ↓ | (Twohig-Bennett & Jones, 2018)2; (Orioli et al., 2019)4 |
Coronary heart disease | ↓ | (Twohig-Bennett & Jones, 2018)2; (Wang et al., 2019)4 |
Diabetes type II/gestational | ↓ | (Twohig-Bennett & Jones, 2018)2; (Bodicoat et al., 2014)4; (Ulmer et al., 2016)4; (Egorov et al., 2017)4; (Yang, Markevych, Heinrich, et al., 2019)4; (Astell-Burt, Feng, et al., 2014b)4; (Qu et al., 2020)4 |
Pre-term birth/small size for gestational age | ↓ | (Twohig-Bennett & Jones, 2018)2 |
Cardiovascular mortality | ↓ | (Twohig-Bennett & Jones, 2018)2; (Yitshak-Sade et al., 2019)4 |
All-cause mortality | ↓ | (Villeneuve et al., 2012)4; (James et al., 2016)4; (Twohig-Bennett & Jones, 2018)2; (Rojas-Rueda et al., 2019)2; (Crouse et al., 2019)4 |
| ||
Psychological/Emotional Parameters | ||
| ||
Well-being | ↑ | (Korpela et al., 2017)4; (Pasanen et al., 2018)4; (Pasanen et al., 2014)4; (MacKerron & Mourato, 2013)4; (Marselle et al., 2013)4; (White et al., 2019)4; (Triguero-Mas et al., 2015)4; (Thompson Coon et al., 2011)2 |
Positive engagement | ||
Revitalization | ||
Tension | ||
Confusion | (Thompson Coon et al., 2011)2 | |
Anger | (Thompson Coon et al., 2011)2 | |
| ||
Risk of Poor Mental Health | ↓ | (Mitchell et al., 2013)34 |
| ||
Emotional Experience | ||
Relaxation | ↑ | (Aspinall et al., 2015)3 |
Frustration | ↓ | |
| ||
Self-esteem | ↑ | (Barton et al., 2012)3; (Barton & Pretty, 2010)2; (Swami et al., 2016)4 |
Body image/appreciation | ↑ | (Swami et al., 2019)4 |
| ||
Stress | ↓ | |
In children | ↓ | (Razani et al., 2019)1 |
In adults | ↓ | (Kondo et al., 2018)4; (Marselle et al., 2013)4; (Nielsen & Hansen, 2007)4; (Largo-Wight et al., 2011)4; (Wooller et al., 2018)1; (Corazon et al., 2018) 4; (Grahn & Stigsdotter, 2003)4 |
Stress related illnesses | ↓ | |
| ||
Risk of Psychological Distress | ↓ | (Francis et al., 2012)4; (Astell-Burt & Feng, 2019)4 |
| ||
Anxiety | ↓ | (Niedermeier et al., 2017)1; (Bratman et al., 2015)1; (Mackay & Neill, 2010)3 |
| ||
Depression | ↓ | (Thompson Coon et al., 2011)2; (Egorov et al., 2017)4; (Irandoust & Taheri, 2017)1 |
| ||
Rumination | ↓ | (Bratman et al., 2015)3 |
| ||
Child resilience | ↑ | (Razani et al., 2019)1 |
| ||
Affective Response | ↑ | (Niedermeier et al., 2017)1 |
Affective valence | ↑ | (Bratman et al., 2015)1 |
Activation | ↑ | (Niedermeier et al., 2017)1 |
Elation | ↑ | (Niedermeier et al., 2017)1 |
Calmness | ↑↓ | (Niedermeier et al., 2017)1 |
Negative affect | ↓ | (Bowler et al., 2010)2; (Thompson Coon et al.,
2011)2 (Marselle et al., 2013)4; (Bratman et al., 2015)1 |
Mood | ↑ | (Barton et al., 2012)3; (Gidlow et al., 2016)3; (Barton & Pretty, 2010)2; (Wooller et al., 2018)1 |
| ||
Energy | ↑ ↔ | (Legrand et al., 2018)1; (Thompson Coon et al., 2011)2; (Kjellgren & Buhrkall, 2010)1 |
Vitality | ↑ | (Bowler et al., 2010)2; (Thompson Coon et al., 2011)2; (Kjellgren & Buhrkall, 2010)1 |
Fatigue | ↓ | (Ryan et al., 2010)1,3; (Niedermeier et al., 2017)1 |
| ||
Self-reported good health | ↑ | (Pasanen et al., 2014)4; (White et al., 2019)4; (Sugiyama & Ward Thompson, 2007)4; (Triguero-Mas et al., 2015)4; (Kyttä et al., 2012)4; (Twohig-Bennett & Jones, 2018)2 |
Health-related Quality of Life | ↑ | |
Poor Health | ↓ | (Stigsdotter et al., 2010)4; (Kim et
al., 2016)4 (Astell-Burt & Feng, 2019)4; (Stigsdotter et al., 2010)4 |
| ||
Cognitive
Function
Cognition & Experience Parameters | ||
| ||
Memory | ↑ | (Gidlow et al., 2016)3; (Flouri et al., 2019)4; (Astell-Burt & Feng, 2020b)4 |
| ||
Direct Attention | ↑ | (Bowler et al., 2010)2; (Rogerson et al., 2016)3 |
| ||
Social Interaction Time | ↑ | (Rogerson et al., 2016)3; (Aram et al., 2019)4; (Rasidi et al., 2012)4 |
| ||
Restoration Experience | ↑ | (Gidlow et al., 2016)3; (Pasanen et al., 2018)4; (Bailey et al., 2018)3 |
| ||
Healthy Child Development | ↑ | (Gill, 2014)2 |
| ||
Intelligence/Academic Performance | ↑ | (Browning & Rigolon, 2019b)2; (Bijnens et al., 2020)4; (Li et al., 2019)4; (Kuo et al., 2018)4 |
| ||
Perception of Required Effort for Exercise |
↑↓
↓ |
(Gladwell et al., 2013)2 (Lahart et al., 2019)2 |
| ||
Nature Engagement | ↑ | (Han & Wang, 2018)3 |
| ||
Frequency of Exercise | ↑ | (Hug et al., 2009)4 |
| ||
Engagement in and Duration of Moderate-to-Vigorous Physical Activity | ↑ | (Beyer et al., 2018)4; (Wood et al., 2014)3; (Byrka & Ryczko, 2018)4; (Cleland et al., 2008)4 |
| ||
Play Styles (Children) | ↑ | (Gill, 2014)2; (Sandseter et al., 2020)4 |
| ||
Social Parameters | ||
| ||
Socialization Opportunities and Activities | ↑ | (Fan et al., 2011)4 |
| ||
Social Support | ↑ | (Fan et al., 2011)4 |
| ||
Social Capital | ↑ | (Holtan et al., 2015)4; (Maas et al., 2009)4 |
| ||
Social Cohesion | ↑ | (Ruijsbroek et al., 2017)4; (de Vries et al., 2013)4; (Sugiyama & Ward Thompson, 2007)4; (Liu et al., 2020)4 |
| ||
Social Mobility | ↑ | (Browning & Rigolon, 2019a)4 |
| ||
Health Care Spending | ↓ | (Becker et al., 2019)4 |
Experimental study design
Literature review or meta-analysis
Quasi experimental study design
Non-experimental/observational study design
↑ Increased
↓ Decreased
↑↓ Conflicting results
↔ No change